89bio (ETNB) News Today $9.60 -0.04 (-0.41%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$9.56 -0.04 (-0.36%) As of 01/31/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period 89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’January 31 at 4:16 PM | markets.businessinsider.comUBS Group Boosts 89bio (NASDAQ:ETNB) Price Target to $38.00UBS Group upped their target price on 89bio from $25.00 to $38.00 and gave the company a "buy" rating in a report on Friday.January 31 at 2:31 PM | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Receives $30.33 Average PT from AnalystsJanuary 31 at 3:37 AM | americanbankingnews.com89bio's SWOT analysis: pegozafermin's potential in MASH and SHTG marketsJanuary 30 at 8:56 PM | msn.com89bio (NASDAQ:ETNB) Stock Price Up 8.3% - Still a Buy?89bio (NASDAQ:ETNB) Trading 8.3% Higher - Here's WhyJanuary 30 at 4:00 PM | marketbeat.com89bio's Pegozafermin Is Now Gaining MomentumJanuary 30 at 7:01 AM | seekingalpha.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's Why89bio (NASDAQ:ETNB) Shares Gap Up - What's Next?January 29 at 8:10 AM | marketbeat.com89bio, Inc. Prices Upsized Public Offering of Common Stock and Pre-funded Warrants Expected to Raise Approximately $250 MillionJanuary 28, 2025 | quiverquant.com89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded WarrantsJanuary 28, 2025 | globenewswire.comWhy 89bio Stock Lagged the Market TodayJanuary 28, 2025 | fool.com89bio (NASDAQ:ETNB) Sees Unusually-High Trading Volume - Still a Buy?89bio (NASDAQ:ETNB) Sees Large Volume Increase - Still a Buy?January 28, 2025 | marketbeat.comTraders Purchase Large Volume of 89bio Call Options (NASDAQ:ETNB)January 28, 2025 | americanbankingnews.com89bio announces $250M common stock offeringJanuary 27, 2025 | markets.businessinsider.comBest, worst of biotech times: One company soars, another stumbles and a third seeks fundsJanuary 27, 2025 | bizjournals.com89bio seeks $250 million in public stock offeringJanuary 27, 2025 | msn.com89bio stock rallies 40% amid data for rival MASH drugJanuary 27, 2025 | msn.com89bio stock falls following public offering announcementJanuary 27, 2025 | msn.com89bio, Inc. Announces $250 Million Underwritten Public Offering of Common StockJanuary 27, 2025 | quiverquant.com89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded WarrantsJanuary 27, 2025 | globenewswire.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's What Happened89bio (NASDAQ:ETNB) Shares Gap Up - Should You Buy?January 27, 2025 | marketbeat.comTraders Buy High Volume of Call Options on 89bio (NASDAQ:ETNB)89bio, Inc. (NASDAQ:ETNB - Get Free Report) was the recipient of some unusual options trading on Monday. Investors bought 2,228 call options on the company. This represents an increase of approximately 346% compared to the typical daily volume of 499 call options.January 27, 2025 | marketbeat.comJPMorgan Chase & Co. Has $736,000 Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)JPMorgan Chase & Co. boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 77.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 99,467 shares of the company's stock after purchasing an aJanuary 27, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from Analysts89bio, Inc. (NASDAQ:ETNB - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have issuedJanuary 26, 2025 | marketbeat.com89bio director McWherter buys $99,850 in stockJanuary 24, 2025 | msn.com89bio, Inc. (NASDAQ:ETNB) Director Acquires $32,750.00 in Stock89bio, Inc. (NASDAQ:ETNB - Get Free Report) Director Charles Mcwherter acquired 5,000 shares of the company's stock in a transaction on Tuesday, January 21st. The stock was acquired at an average cost of $6.55 per share, for a total transaction of $32,750.00. Following the completion of the acquisition, the director now owns 15,000 shares of the company's stock, valued at $98,250. This trade represents a 50.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink.January 23, 2025 | marketbeat.comCantor Fitzgerald Weighs in on 89bio FY2025 Earnings89bio, Inc. (NASDAQ:ETNB - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for 89bio in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per shJanuary 23, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Earns "Buy" Rating from HC WainwrightJanuary 23, 2025 | americanbankingnews.comAssenagon Asset Management S.A. Invests $1.90 Million in 89bio, Inc. (NASDAQ:ETNB)Assenagon Asset Management S.A. purchased a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 242,602 shares of the company's stock, valued at approJanuary 23, 2025 | marketbeat.com89bio’s Promising Drug Developments and Stable Financial Outlook Justify Buy RatingJanuary 22, 2025 | markets.businessinsider.com89bio shares maintain Buy rating as analyst cites confidence in pegozafermin trial outcomesJanuary 21, 2025 | msn.comHC Wainwright Reiterates Buy Rating for 89bio (NASDAQ:ETNB)HC Wainwright reiterated a "buy" rating and issued a $29.00 target price on shares of 89bio in a research note on Tuesday.January 21, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Takes $739,000 Position in 89bio, Inc. (NASDAQ:ETNB)Hennion & Walsh Asset Management Inc. bought a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 94,494 shares of the company's stock, valued at approximately $739,000. HennJanuary 20, 2025 | marketbeat.comWeiss Ratings Reiterates Sell (D-) Rating for 89bio (NASDAQ:ETNB)Weiss Ratings restated a "sell (d-)" rating on shares of 89bio in a report on Saturday.January 19, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Short Interest Up 12.2% in December89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 7,790,000 shares, an increase of 12.2% from the December 15th total of 6,940,000 shares. Based on an average trading volume of 943,200 shares, the days-to-cover ratio is currently 8.3 days.January 18, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Insider Quoc Le-Nguyen Sells 10,963 SharesJanuary 18, 2025 | insidertrades.com89bio's chief technical operations officer sells $71,149 in stockJanuary 17, 2025 | msn.com89bio, Inc. (NASDAQ:ETNB) Insider Sells $71,149.87 in Stock89bio, Inc. (NASDAQ:ETNB - Get Free Report) insider Quoc Le-Nguyen sold 10,963 shares of the company's stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $6.49, for a total transaction of $71,149.87. Following the transaction, the insider now directly owns 271,833 shares of the company's stock, valued at $1,764,196.17. This trade represents a 3.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.January 17, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Reaches New 12-Month Low - Time to Sell?89bio (NASDAQ:ETNB) Sets New 12-Month Low - Should You Sell?January 17, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 4% - Time to Sell?89bio (NASDAQ:ETNB) Stock Price Down 4% - Time to Sell?January 16, 2025 | marketbeat.com89bio’s Pegozafermin: Promising Strategic Outlook and Phase 3 DevelopmentsJanuary 15, 2025 | markets.businessinsider.com89bio: Advancement Of Pegozafermin For SHTG Is Another Path ForwardJanuary 13, 2025 | seekingalpha.com89bio provides business update, outlook 2025January 13, 2025 | markets.businessinsider.com89bio Provides Business Update and Outlook for 2025January 13, 2025 | markets.businessinsider.comBarclays PLC Acquires 149,479 Shares of 89bio, Inc. (NASDAQ:ETNB)Barclays PLC increased its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 228.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 214,768 shares of the company's stock after buying aJanuary 12, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Reaches New 52-Week Low - Should You Sell?89bio (NASDAQ:ETNB) Sets New 12-Month Low - Time to Sell?January 11, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Trading Down 8.2% - Here's What Happened89bio (NASDAQ:ETNB) Trading Down 8.2% - What's Next?January 10, 2025 | marketbeat.comCantor Fitzgerald Reaffirms Their Buy Rating on 89bio (ETNB)January 2, 2025 | markets.businessinsider.com89bio (NASDAQ:ETNB) Earns "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $29.00 target price on shares of 89bio in a research report on Thursday.January 2, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Receives Average Rating of "Moderate Buy" from Analysts89bio, Inc. (NASDAQ:ETNB - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven research firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendatJanuary 1, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Stock Price Down 3.7% - Should You Sell?89bio (NASDAQ:ETNB) Trading Down 3.7% - Time to Sell?December 31, 2024 | marketbeat.com Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.540.69▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼275▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viking Therapeutics News Apellis Pharmaceuticals News Avidity Biosciences News Akero Therapeutics News PTC Therapeutics News Crinetics Pharmaceuticals News Rhythm Pharmaceuticals News Arcellx News Denali Therapeutics News Immunovant News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
